Fresenius | FRE - Sales Revenues

Stock Price
49.18
Daily Change
-0.05 -0.10%
Monthly
1.53%
Yearly
34.12%
Q1 Forecast
45.82

Fresenius reported EUR5.48B in Sales Revenues for its fiscal quarter ending in September of 2025.





Sales Change Date
Akzo Nobel EUR 2.37B 180M Dec/2025
Alcon AG USD 2.59B 10M Sep/2025
AstraZeneca USD 15.19B 733M Sep/2025
BASF EUR 14.33B 1.44B Sep/2025
Bayer EUR 9.66B 1.08B Sep/2025
Beiersdorf EUR 2.35B 150M Sep/2025
DaVita Healthcare Partners USD 3.62B 200M Dec/2025
Demant DKK 6.26B 810M Dec/2025
E.ON EUR 15.96B 380M Sep/2025
Essilor EUR 6.87B 0 Sep/2025
Fresenius EUR 5.48B 100M Sep/2025
Fresenius Medical Care EUR 4.89B 100M Sep/2025
Getinge SEK 11.07B 3.2B Dec/2024
Givaudan CHF 1.87B 1.51B Jun/2024
GlaxoSmithKline GBP 8.62B 73M Dec/2025
GN Store Nord DKK 4.68B 718M Dec/2025
GRIFOLS EUR 1.87B 20M Sep/2025
Hikma Pharmaceutical USD 829M 758M Jun/2025
Lonza CHF 3.58B 63M Jun/2025
Merck EUR 5.32B 890M Sep/2025
Novartis USD 13.91B 144M Sep/2025
Philips EUR 4.3B 38M Sep/2025
Roche Holding CHF 15.65B 274.5M Dec/2025
RWE EUR 3.21B 510M Sep/2025
Sanofi EUR 11.3B 1.13B Dec/2025
Smith & Nephew USD 2.96B 134M Dec/2025